These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30213212)

  • 1. Triple antithrombotic therapy in patients with atrial fibrillation undergoing PCI: current evidence and practice.
    Clarke A; Ibrahim A; Kiernan TJ
    Expert Rev Cardiovasc Ther; 2018 Oct; 16(10):715-723. PubMed ID: 30213212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Camaj A; Miller MS; Halperin JL; Giustino G
    Cardiol Clin; 2020 Nov; 38(4):551-561. PubMed ID: 33036717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation.
    Lou B; Liang X; Wu Y; Deng Y; Zhou B; Yuan Z; She J
    Am J Cardiol; 2018 Aug; 122(4):604-611. PubMed ID: 30205887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Hoshi T; Sato A; Nogami A; Gosho M; Aonuma K;
    J Cardiol; 2017 Apr; 69(4):648-651. PubMed ID: 27443596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Cavallari I; Patti G
    Am J Cardiol; 2018 Mar; 121(6):718-724. PubMed ID: 29373105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Angiolillo DJ; Bhatt DL; Cannon CP; Eikelboom JW; Gibson CM; Goodman SG; Granger CB; Holmes DR; Lopes RD; Mehran R; Moliterno DJ; Price MJ; Saw J; Tanguay JF; Faxon DP
    Circulation; 2021 Feb; 143(6):583-596. PubMed ID: 33555916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
    Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
    Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble.
    Leggio M; Fusco A; Severi P; Lombardi M; Caldarone E; D'Emidio S; Armeni M; Mereu D; Bendini MG; Mazza A
    Drugs; 2018 Sep; 78(13):1309-1319. PubMed ID: 30132258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation.
    Ho KW; Ivanov J; Freixa X; Overgaard CB; Osten MD; Ing D; Horlick E; Mackie K; Seidelin PH; Džavík V
    Can J Cardiol; 2013 Feb; 29(2):213-8. PubMed ID: 23089528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy.
    Fitchett D; Verma A; Eikelboom J; Madan M; Cohen E; Bell A; Dorian P
    Curr Opin Cardiol; 2014 Jan; 29(1):1-9. PubMed ID: 24284976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management.
    Deshmukh A; Hilleman DE; Del Core M; Nair CK
    Am J Ther; 2013; 20(6):654-63. PubMed ID: 21519218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis.
    Vitolo M; Javed S; Capodanno D; Rubboli A; Boriani G; Lip GYH
    Expert Rev Cardiovasc Ther; 2020 Sep; 18(9):587-600. PubMed ID: 32772746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy for patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention: a review.
    Krasner A; Halperin JL
    Curr Cardiol Rep; 2013 Jul; 15(7):378. PubMed ID: 23689944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint.
    Gwyn JCV; Thomas MR; Kirchhof P
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):157-162. PubMed ID: 28329215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.